Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India

MLA

Arihant Jain, et al. “Outcomes of Patients with Hematologic Malignancies and COVID-19 from the Hematologic Cancer Registry of India.” Blood Cancer Journal, vol. 12, no. 1, Jan. 2022, pp. 1–5. EBSCOhost, https://doi.org/10.1038/s41408-021-00599-w.

APA

Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, Sharat Damodar, Joseph M. John, Prashant Mehta, Suvir Singh, Pritesh Munot, Sushil Selvarajan, Venkatraman Radhakrishnan, Deepesh Lad, Rajan Kapoor, Biswajit Dubashi, Ram S. Bharath, Hasmukh Jain, P. K. Jayachandran, … Pankaj Malhotra. (2022). Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India. Blood Cancer Journal, 12(1), 1–5. https://doi.org/10.1038/s41408-021-00599-w

Chicago

Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, Sharat Damodar, et al. 2022. “Outcomes of Patients with Hematologic Malignancies and COVID-19 from the Hematologic Cancer Registry of India.” Blood Cancer Journal 12 (1): 1–5. doi:10.1038/s41408-021-00599-w.